2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(8¿ù 30ÀÏ) : 2018-08-30±³À°ÀÏÀÚ : 2018-08-30
±³À°Àå¼Ò : ¹é½ºÄÚ ±×·£µåº¼·ë ¿Ü
±³À°ÁÖÁ¦ :
2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(8¿ù 30ÀÏ) ÁÖÃÖ±â°ü : ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú)
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
bmt@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í Á¤È¸¿ø(Àü¹®ÀÇ) £Ü100,000, ÁØȸ¿ø(°£È£»ç/Àü°øÀÇ/¿¬±¸¿ø) £Ü50,000- 5¿ù 31ÀÏ(¸ñ)±îÁöÁ¤È¸¿ø(Àü¹®ÀÇ) £Ü150,000, ÁØȸ¿ø(°£È£»ç/Àü°øÀÇ/¿¬±¸¿ø) £Ü80,000- 7¿ù 31ÀÏ(È)±îÁö ÇöÀåµî·Ïºñ : Á¤È¸¿ø(Àü¹®ÀÇ) £Ü200,000, ÁØȸ¿ø(°£È£»ç/Àü°øÀÇ/¿¬±¸¿ø) £Ü100,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08¿ù 30ÀÏ Grand Ballroom 10:20~11:00 Car-T cell in hematologic maligncy Sattva S.Neelapu(USA)
±³À°½Ã°£ 08¿ù 30ÀÏ Grand Ballroom 11:00~11:40 Optimal conditioning for allogeneic stem cell transplantation Nicolaus Kröger(Germany)
±³À°½Ã°£ 08¿ù 30ÀÏ Hall A 12:00~12:50 Strategies for treatment MF focusing on OS benefit Martin Griesshammer(Germany)
±³À°½Ã°£ 08¿ù 30ÀÏ Hall A 13:30~14:10 Immunobiology of GVHD Pavan Reddy(USA)
±³À°½Ã°£ 08¿ù 30ÀÏ Hall A 14:10~14:35 Translational research of acute GVHD ±èº´¼ö(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 08¿ù 30ÀÏ Hall A 14:35~15:00 Current issues in the management of acute GVHD ½ÅÈ£Áø(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 08¿ù 30ÀÏ Hall B 15:30~16:00 Stem cell transplantation in follicular lymphoma and chronic lymphocytic leukemia Wei Xu(France)
±³À°½Ã°£ 08¿ù 30ÀÏ Hall B 16:00~16:30 Novel agents in follicular lymphoma and chronic lymphocytic leukemia Franck Morschhauser(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 08¿ù 30ÀÏ Hall B 16:30~17:00 Management of mantle cell lymphoma °í¿µÀÏ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 08¿ù 30ÀÏ Hall A 17:00~18:00 Tumor-induced myelopoiesis and immune suppression À±Á¦ÀÎ(¿¬¼¼ÀÇ´ë)